BPA Call HT941024A0007-HT941026FE041
Award Date 4/15/26
Potential Completion Date 4/30/26
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on November 5, 2025, for VITROS chemistry and immunoassay analyzer testing reagents and consumables, with a ceiling value of $50,053.35. The call is issued under a $2.875 million single-award BPA with the Defense Health Agency, effective July 1, 2024, through June 30, 2029, for chemistry and immunoassay testing system reagents and consumable supplies for VITROS 7600 laboratory equipment at Yokota Air Base and other...
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. under the Chemistry and Immunoassay Testing System Reagents and Consumable Supplies BPA for VITROS analyzer reagents and consumables, with a ceiling value of $11,472.90 and an award date of December 15, 2025. The parent BPA, valued at $2.875 million and effective July 1, 2024, through June 30, 2029, supports VITROS 7600 laboratory testing equipment consumables for use at Yokota Air Base and other U.S. military medical...
- Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. valued at $41,780.36 under a single-award Blanket Purchase Agreement for Chemistry and Immunoassay Testing System reagents and consumable supplies, with an award date of March 11, 2026 and ultimate completion date of March 31, 2026. The parent BPA, effective July 1, 2024 through June 30, 2029 with a ceiling of $2,875,000, covers VITROS 7600 laboratory testing equipment consumables for use at Yokota Air Base and other U.S....
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on December 2, 2025, for chemistry and immunoassay testing system reagents and supplies, with a ceiling value of $58,986.39. The call is issued under a $2,875,000 single-award BPA effective July 1, 2024, through June 30, 2029, for VITROS 7600 laboratory testing equipment consumables supporting U.S. military medical facilities throughout Japan. Performance occurs in Japan and is scheduled for completion by March 26,...
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. for chemistry and immunoassay testing system reagents and supplies, with a ceiling value of $69,442.40, awarded July 28, 2025. The call is issued under a $2,875,000 single-award BPA with the Defense Health Agency effective July 1, 2024 through June 30, 2029, for VITROS 7600 laboratory testing equipment consumables supporting U.S. military medical facilities in Japan. Performance occurs in Japan with an ultimate...
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on April 9, 2026, under a $2,875,000 single-award blanket purchase agreement for chemistry and immunoassay testing system reagents and supplies, with a call ceiling of $18,432.42. Performance occurs in Japan with an ultimate completion date of April 30, 2026. The call procures VITROS 7600 laboratory testing equipment consumables for use at Yokota Air Base and other U.S. military medical facilities throughout Japan....
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. for chemistry and immunoassay testing system reagents and supplies, with a ceiling value of $35,907.65 and an award date of March 10, 2026. The call was issued under a $2.875 million single-award BPA with the Defense Health Agency (effective July 1, 2024 through June 30, 2029) for VITROS 7600 laboratory testing equipment consumables. Performance occurs in Japan and is scheduled for completion by March 31, 2026. The...
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on February 2, 2026, for VITROS reagent and supplies, with a ceiling value of $45,974.02 and completion date of February 15, 2026. The call is issued under a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $250,000, awarded October 1, 2025, through September 30, 2030, for laboratory medical supplies supporting the Medical Department Activity in Japan. Performance occurs in Japan. The...
- The Defense Health Agency awarded a $17,255.88 blanket purchase agreement (BPA) call to Ortho Clinical Diagnostics K.K. for VITROS chemistry and immunoassay analyzer testing reagents and consumables. This firm fixed-price contract, awarded on January 28, 2026, with a completion date of February 13, 2026, supports clinical laboratory diagnostic operations at U.S. military medical facilities throughout Japan. The award carries no socioeconomic set-aside designation and represents a delivery...
- The Defense Health Agency awarded a $50,949.59 firm fixed-price BPA call to Ortho Clinical Diagnostics K.K. on September 23, 2025, for chemistry and immunoassay testing system reagents and supplies. The contract will be completed by October 24, 2025, and performance will occur in Japan. This award represents a delivery order under Ortho Clinical Diagnostics K.K.'s existing $2.875M single-award Blanket Purchase Agreement with the Defense Health Agency, which has been in effect since July 1, 2024,...